Author | Yuly A. Remolina-Bonilla, MD

Articles

Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic

August 12, 2020

Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab

May 13, 2020

Experts discuss the case of a 56-year-old white man who presents with multiple immune-related adverse events

What Are Treatment Options After Progression in PDL-1–Positive Metastatic Lung Adenocarcinoma after Chemo/IO?

August 23, 2019

What is the best treatment option after progression to chemotherapy/immunotherapy (chemo/IO) as first-line treatment for PD-L1–positive lung adenocarcinoma with no sensitizing mutations?